Balance Sheet Insights: Reviva Pharmaceuticals Holdings Inc (RVPH)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Kevin Freeman

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In the latest session, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed at $0.68 down -19.15% from its previous closing price of $0.84. In other words, the price has decreased by -$19.15 from its previous closing price. On the day, 36.15 million shares were traded. RVPH stock price reached its highest trading level at $0.7727 during the session, while it also had its lowest trading level at $0.56.

Ratios:

For a deeper understanding of Reviva Pharmaceuticals Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $2.

On September 20, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $12.

On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.The Benchmark Company initiated its Speculative Buy rating on June 08, 2023, with a $17 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 65422536 and an Enterprise Value of 35930784.

Stock Price History:

The Beta on a monthly basis for RVPH is -0.18, which has changed by -0.4137931 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $4.28, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 49.89%, while the 200-Day Moving Average is calculated to be -27.32%.

Shares Statistics:

For the past three months, RVPH has traded an average of 6.35M shares per day and 25354480 over the past ten days. A total of 96.34M shares are outstanding, with a floating share count of 86.12M. Insiders hold about 10.60% of the company’s shares, while institutions hold 14.38% stake in the company. Shares short for RVPH as of 1757894400 were 13010726 with a Short Ratio of 2.05, compared to 1755216000 on 11607591. Therefore, it implies a Short% of Shares Outstanding of 13010726 and a Short% of Float of 21.120001.

Earnings Estimates

The stock of Reviva Pharmaceuticals Holdings Inc (RVPH) is currently drawing attention from 6.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.06 and low estimates of -$0.14.

Analysts are recommending an EPS of between -$0.36 and -$0.52 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.37, with 6.0 analysts recommending between $0.0 and -$0.85.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.